Global Urinary Incontinence Market, By Diagnosis (Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples), Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence), Treatment Type (Medication, Devices, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years, the urinary incontinence market is anticipated to grow rapidly during the forecast period. According to the study "Prevalence of Urinary Incontinence among Young Healthy Females in Gujarat - A Cross-sectional Study," the prevalence of UI was 71.85 percent among young women aged 18-25 years who were healthy, with 50.85 percent having stress, 9.16 percent having urge, and 40 percent having a mixed type of urinary incontinence after an 11-month study period from December 2017 to October 2018, among the total population. Several organizations are now working on devices designed specifically for women. They're launching a variety of small, tampon-like disposable devices for daily use, as well as flexible silicone rings to prevent urine leakage and support the urethra in women with vaginal prolapse.
Data Bridge Market Research analyses that the urinary incontinence market was valued at USD 10,863.3 million in 2021 and is expected to reach USD 19,088.09 million by 2029, registering a CAGR of 7.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Incontinence is the term for any unintentional urine leaking. Male urine incontinence is most frequently caused by a damaged sphincter or a faulty bladder. In the bladder, the sphincter is a circular muscle that controls urine flow. When the urethra, the tube that takes urine from the bladder to the outside of the body, is wounded, this muscle loses its capacity to squeeze and close it. Urinary incontinence devices help with urine collection and retention, as well as urinary incontinence management. Urinary incontinence is a condition in which pee leaks out uncontrollably.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diseases (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Acute Bacterial Skin and Skin Structure Infections, Hospital Acquired Bacterial Pneumonia, Acquired Bacterial Pneumonia, Others), Pathogen (E. coli, P. Aeruginosa, K. Pneumoniae, Others), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Zydus Cadila (India), Torrent Pharmaceuticals Ltd. (India), Apotex Inc., Eli Lilly and Company (US), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Israel), Alembic Pharmaceuticals Limited (India), Coloplast Group (Denmark), Boston Scientific Corporation (US), Alembic Pharmaceuticals Limited (India), B. Braun Melsungen AG (Germany), BD (US), Baxter (US), Johnson & Johnson Private Limited (US), Medtronic (Ireland), AstraZeneca (UK), Merck & Co., Inc. (US)
|
|
Market Opportunities
|
|
Urinary Incontinence Market Dynamics
Drivers
- Rise in the prevalence of urinary incontinence
The increased prevalence of urinary incontinence is a major factor driving market expansion (UI). Urinary incontinence symptoms can be caused by a variety of reasons, including urinary tract infection, weakening of pelvic floor muscles and urethral sphincters, menopause, pregnancy, childbirth, and post-radical prostatectomy surgery in men.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of urinary incontinence market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness and increasing number of cases of diabetes, obesity and neurological diseases will expand the urinary incontinence market. Additionally, high disposable income and increasing trend of non-invasive treatment options will result in the expansion of urinary incontinence market. Along with this, rising geriatric population and rising incidences of chronic diseases will enhance the growth rate of the market. Surge in the consumption of sweeteners, caffeine, carbonated drinks, chocolates, sparkling water, muscle relaxants and artificial chili peppers can enhance the risk of urinary incontinence and hence further projected to cushion the market’s growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the urinary incontinence market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the urinary incontinence market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the treatment and devices will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies will challenge the urinary incontinence market. Additionally, the dearth of skilled professionals and complications involved with the procedures will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This urinary incontinence market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinary incontinence market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Urinary incontinence market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Urinary Incontinence Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of urinary incontinence in recent months.
Recent Development
- In May 2020, Rigicon had announced the launch of two new artificial urinary sphincter models named ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter. AUS stands for Artificial Urine Sphincter and is a medical device used to treat urinary incontinence. When non-surgical and behavioural treatment approaches fail, the Artificial Urinary Sphincter is a surgical treatment option.
Global Urinary Incontinence Market Scope
The urinary incontinence market is segmented on the basis of diagnosis, type, treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
- Physical Exam
- Pad Test
- Urodynamic Testing
- Cystoscopy
- Stress Test
- Ultrasound
- Urine Samples
Type
- Stress Incontinence
- Urge Incontinence
- Overflow Incontinence
Treatment Type
- Medication
- Devices
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Urinary Incontinence Market Regional Analysis/Insights
The Urinary incontinence market is analysed and market size insights and trends are provided by country, diagnosis, type, treatment type, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Urinary incontinence market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the urinary incontinence market because of the surging adoption of newer techniques in this region. Additionally, growing presence of major key players and well-established healthcare infrastructure will further propel the market’s growth rate in this region.
Asia-Pacific are expected to grow during the forecast period due to surging number of generic manufacturers and rising government initiatives in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Urinary Incontinence Market Share Analysis
The Urinary incontinence market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinary incontinence market.
Some of the major players operating in the urinary incontinence market are:
- Zydus Cadila (India)
- Torrent Pharmaceuticals Ltd. (India)
- Apotex Inc.
- Eli Lilly and Company (US)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Alembic Pharmaceuticals Limited (India)
- Coloplast Group (Denmark)
- Boston Scientific Corporation (US)
- Alembic Pharmaceuticals Limited (India)
- B. Braun Melsungen AG (Germany)
- BD (US)
- Baxter (US)
- Johnson & Johnson Private Limited (US)
- Medtronic (Ireland)
- AstraZeneca (UK)
- Merck & Co., Inc. (US)
SKU-